Chlorhexidine-alcohol compared with povidone-iodine for surgical-site antisepsis in cesarean deliveries

Obstetrics and Gynecology

Volumn 120, Issue 5, 2012, Pages 1037-1044

  Menderes, Gulden ^a   Athar Ali, Nishath ^a   Aagaard, Kjersti ^a   Sangi Haghpeykar, Haleh ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL PLUS CHLORHEXIDINE GLUCONATE; POVIDONE IODINE;

ADULT; ANTISEPSIS; ARTICLE; BODY MASS; CESAREAN SECTION; COMORBIDITY; DRUG EFFICACY; FEMALE; HUMAN; INFECTION CONTROL; OPERATION DURATION; OUTCOME ASSESSMENT; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING; SURGICAL INFECTION;

ADOLESCENT; ADULT; ANTISEPSIS; CESAREAN SECTION; CHLORHEXIDINE; COHORT STUDIES; ETHANOL; FEMALE; HUMANS; POVIDONE-IODINE; PREGNANCY; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84868092736     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31826f3bd9     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention, National Center for Health Statistics. Vital and Health Statistics, series 23, number 30. Available at: www.cdc.gov/nchs/data/series/sr-13/sr13-168.pdf. Retrieved May 3, 2012.
2. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006;43:322-30.
3. Centers for Disease Control and Prevention, Guideline for prevention of surgical site infection, 1999. Available at: www.cdc. gov/hicpac/pdf/guidelines/ SSI-1999.pdf. Retrieved May 3, 2012.
4. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009;37:387-97.
5. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical site infection in the 1990s: attributable mortality, excess length of hospitalization and extra costs. Infect Control Hosp Epidemiol 1999;20:725-30.
6. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. August 9, 2002/51(RR10);1-26 Available at: http://www. cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm. Retrieved May 3, 2012.
7. Culligan PJ, Kubik K, Murphy M, Blackwell L, Snyder J. A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomy. Am J Obstet Gynecol 2005;192:422-5.
8. Paocharoen V, Mingmalairak C, Apisarnthanarak A. Comparison of surgical wound infection after preoperative skin preparation with 4% chlorhexidine [correction of chlohexidine] and povidone iodine: a prospective randomized trial. J Med Assoc Thai 2009;92:898-902.
9. Darouiche RO, Wall MJ, Itani KMF. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis, N Engl J Med 2010;362:18-26.
10. Noorani A, Rabey N, Walsh SR, Davies RJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone-iodine in clean-contaminated surgery. Br J Surg 2010;9:1614-20.
11. Swenson BR, Hedrick TL, Metzger R, Bonatti H, Pruett TL, Sawyer RG. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol 2009;30: 964-71.
12. Brown TR, Ehrlich CE, Stehman FB, Golichowski AM, Madura JA, Eitzen HE. A clinical evaluation of chlorhexidine gluconate spray as compared with iodophor scrub for preoperative skin preparation. Surg Gynecol Obstet 1984;158:363-6.
13. Levin I, Am-Alshiek J, Avni A, Lessing JB, Satel A, Almog B. Chlorhexidine and alcohol versus povidone-iodine for antisepsis in gynecological surgery. J Womens Health (Larchmt) 2011; 20:321-4.
14. Declercq E, Barger M, Cabral HJ, Evans SR, Kotelchuck M, Simon C, et al. Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births. Obstet Gynecol 2007;109:669-77.
15. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Available at: http://www.cdc.gov/nhsn/ PDFs/dataStat/NNIS-2004. Retrieved May 3, 2012.
16. Centers for Disease Control and Prevention. NCHS Data Brief. Recent trends in cesarean Delivery in the United States. Number 35, March 2010. Available at: www.cdc.gov/nchs/data/databriefs/db35.htm. Retrieved May 3, 2012.
17. Maiwald M, Widmer AF, Rotter ML. Lack of evidence for attributing chlorhexidine as the main active ingredient in skin antiseptics preventing surgical site infections. Infect Control Hosp Epidemiol 2011;32:404-5.
18. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Inf Cont 2009;37:783-805.
19. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J, Pearson A, et al. Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection. Health Technol Assess 2011;15:1-156.
20. Wojkowska-Mach J, Batycki R, Hulboj D, Bulanda M, Rozanska A, Heczko PB. Hospital-acquired infections after cesarean delivery in selected hospitals in the southern Poland. Ginekol Pol 2008;79:536-43.
21. Rauk PN. Educational intervention, revised instrument sterilization methods, and comprehensive preoperative skin preparation protocol reduce cesarean section surgical site infections. Am J infect Control 2010;38:319-23.
22. Kaimal AJ, Zlatnik MG, Cheng YW, Thiet MP, Connatty E, Creedy P, et al. Effect of a change in policy regarding the timing of prophylactic antibiotics on the rate of post-cesarean delivery surgical-site infections. Am J Obstet Gynecol 2008;199:310.e1-5.
23. Lamont RF, Sobel JD, Kusanovic JP, Vaisbuch E, Mazaki-Tovi S, Kim SK, et al. Current debate on the use of antibiotic prophylaxis for caesarean section. BJOG 2011;118: 193-201.
24. Kittur ND, McMullen KM, Russo AJ, Ruhl L, Kay HH, Warren DK. Long-term effect of infection prevention practices and case mix on cesarean surgical site infections. Obstet Gynecol 2012;120:246-51.
25. Boltz MM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery 2011; 150:934-42.